Study of the Adjuvant Properties of Chitosan in Complex with Recombinant Outer Membrane Protein F and Recombinant Toxoid Pseudomonas Aeruginosa

Main Article Content

A.A. Kaloshin
N.A. Mihailova

Abstract

The aim of the study was to investigate adjuvant properties of chitosan in comparison with aluminum hydroxide during immunization with recombinant proteins of Pseudomonas aeruginosa. We used recombinant outer membrane protein F (OprF) and recombinant toxoid of P. aeruginosa, to which 0.5% chitosan preparation dissolved in glutamic acid with pH 5.0 or aluminum hydroxide gel were added. The ratios of aluminum hydroxide to protein of 3:1 and 1:1 were tested, and chitosan was added at 100 μg and 50 μg for one immunizing dose. The resulting preparations were administered to mice intraperitoneally twice with a two-week interval, and then two weeks later the animals were infected intraperitoneally with P. aeruginosa (PA-103). It was shown that double administration of the recombinant OprF protein at a dose of 25 μg and recombinant toxoid at a dose of 50 μg with both aluminum hydroxide and chitosan contributed to the development of equivalent protective properties. With the complex introduction of two recombinant proteins, an increase in protective properties was observed using both adjuvants. The possibility of using antigens without adjuvant and reducing their immunizing dose during booster immunization was investigated. It turned out that a two-fold reduction in the immunizing dose did not reduce the protective effect upon repeated administration, and in the case of chitosan, an increase in the immune response was observed during booster immunization with recombinant antigens without an adjuvant. Thus, for the recombinant proteins of P. aeruginosa, the adjuvant properties of chitosan were revealed. They are not inferior in the induction of protective properties to aluminum hydroxide.

Article Details

How to Cite
Kaloshin, A., & Mihailova, N. (2025). Study of the Adjuvant Properties of Chitosan in Complex with Recombinant Outer Membrane Protein F and Recombinant Toxoid Pseudomonas Aeruginosa. Biomedical Chemistry: Research and Methods, 8(1), e00252. https://doi.org/10.18097/BMCRM00252
Section
EXPERIMENTAL RESEARCH

References

  1. Lazareva, A.V., Tchebotar, I.V., Kryzhanovskaya, O.A., Tchebotar, V.I.,Mayanskiy, N.A. (2015) Pseudomonas aeruginosa: pathogenicity, pathogenesisand diseases. Klinicheskaya Mikrobiologiya i Antimikrobnaya Khimioterapiya,17(3), 170-186.
  2. Kaloshin, A.A., Mihailova, N.A., Vasiliev, Y.M. (2021) Obtaining, evaluatingof specific activity and authenticity of recombinant vaccine for prevention ofPseudomonas aeruginosa infection. Infection and Immunity, 11(4), 763-770. DOI
  3. Gupta, R.K., Siber, G.R. (1995) Adjuvants for human vaccines-currentstatus, problems and future prospects. Vaccine, 13(14), 1263-1276. DOI
  4. Tolstikov, G.A., Flekhter, O.B., Shults, E.E., Baltina, L.A., Tolstikov, A.G.(2005) Betulin and its derivatives. Chemistry and biological activity. Chemistryfor sustainable development, 1, 1-30.
  5. Pashchenkov, M.V., Popilyuk, S.F., Alkhazova, B.I., L’vov, V.L., Fedenko,E.S., Khaitov, R.M., Pinegin, B.V. (2010) Immunobiological properties ofmuramylpeptide fragments of peptidoglycan from gram-negative bacteria.Immunologiya, 31(3), 119-125.
  6. Dmour, I., Islam, N. (2021) Recent advances on chitosan as an adjuvant forvaccine delivery. Int. J. Biol. Macromol., 30(200), 498-519. DOI
  7. Varlamov, V.P., Il’ina, A.V., Shagdarova, B.Ts., Lunkov, A.P., Mysyakina, I.S.(2020) Chitin/chitosan and its derivatives: fundamental and applied aspects.Advances in biological chemistry, 60, 317-368.
  8. Kurashova, S.S., Dzagurova, T.K., Ishmukhametov, A.A., Egorova, M.S.,Balovneva, M.V., Sotskova, S.E., Tkachenko, E.A. (2018) Carbohydrate-basedadjuvants for vaccine production. BIOpreparations. Prevention, Diagnosis,Treatment, 18(2), 81-91. DOI
  9. Vasiliev, Y.M. (2015) Chitosan-based vaccine adjuvants: incompletecharacterization complicates preclinical and clinical evaluation. Expert. Rev.Vaccines, 14(1), 37-53. DOI
  10. Markushin S.G., Pereversev A.D., Koptiaeva I.B., Krivtsov G.G., SuchnoA.S. (2010) Comparative investigation of adjuvant properties of differentchitosan derivatives at mucosal vaccination by live and inactivated influenzavaccines. Epidemiology and Vaccinal Prevention, 5(54), 82-85.
  11. Khantimirova, L.M., Vasilev, Yu.M., Kashirina, O.S., Chernikova, M.I.,Kaloshin, A.A., Mikhajlova, N.A., Ilina, A.V., Lopatin, S.A., Varlamov, V.P.(2019) Immunoadjuvant composition for vaccines for infectious agents of viraland bacterial nature. Patent for invention RU 2697527 C1.
  12. Kaloshin, A.A., Gatypova, E.V., Mikhailova, N.A. (2011) Obtainingrecombinant forms of the outer membrane protein F of Pseudomonasaeruginosa and assessment of their immunogenic properties. AppliedBiochemistry and Microbiology, 47(8), 780-788. DOI
  13. Kaloshin, A.A., Isakov, M.A., Mikhailova, N.A., Vertiev, Ju.V. (2013)Preparation of recombinant atoxic form of exotoxin a from Pseudomonasaeruginosa. Bulletin of Experimental Biology and Medicine, 154(3), 346-350. DOI
  14. Osterman, L.A. (1981) Research methods of proteins and nucleic acids:Electrophoresis and ultracentrifugation (practical guide). Moscow: Nauka, 288p.
  15. Ashmarin, I.P., Vorobyov, A.A. (1962) Statistical methods in microbiologicalresearch. Leningrad: Medgiz, 180 p.